| PL-NAb (BAU/mL) | Outcome |
| 0–50 | Negative for NAb |
| 51–100 | Borderline or low positive for NAb (not protected) |
| 101–1000 | Moderately protective immunity |
| >1000 | Fully protected (in terms of SARS-CoV-2 disease severity) |
| PL-NAb (BAU/mL) | Outcome |
| 0–50 | Negative for NAb |
| 51–100 | Borderline or low positive for NAb (not protected) |
| 101–1000 | Moderately protective immunity |
| >1000 | Fully protected (in terms of SARS-CoV-2 disease severity) |